Abstract
Introduction: The relationship between neurological and cardiovascular processes has been widely substantiated from strict pathophysiological and biochemical bases in both systems. Atrial fibrillation is responsible for 25% of ischemic strokes of cardioembolic origin, however in a significant volume of patients whose admission occurs due to an initial or recurrent event of cerebral infarction, the existence of this condition is unknown and its diagnosis is made during admission.
Objective: To characterize patients with cardioembolic cerebral infarction secondary to atrial fibrillation.
Methods: Cross-sectional descriptive study of 162 patients admitted to the neurological service with a diagnosis of ischemic stroke. The sample was made up of 42 patients with coexisting atrial fibrillation. Parameters of age sex, quantitative neurological damage, associated comorbidities and compromised arterial territory were studied.
Results: Atrial fibrillation was found in 25.9% of cases, with a predominance of the male sex, the average age of the patients was 73.4 years (SD=8.5), reaching a prevalence of 32% in people over 75 years of age, the main personal pathological history was arterial hypertension and smoking, a greater involvement of the left cerebral artery was detected for 38.09% and moderate motor deficit predominated.
Conclusions: It is necessary to perform serial electrocardiographic monitoring of patients with cerebral ischemic strokes as part of the follow-up policies to anticipate complications and avoid recurrence.
References
1. Yadava M, Fanaroff AC, Bernstein RA. Cardioembolic Stroke. Neurol Clin. 2024;42(3):651-61. https://doi.org/10.1016/j.ncl.2024.02.010
2. Morales-Bacas E, Duque-Holguera M, Portilla-Cuenca JC, Casado-Naranjo I. Fibrilación auricular y deterioro cognitivo. Rev Neurol. 2022;75(10):311-8. https://doi.org/10.33588/rn.7510.2022186
3. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-21. https://doi.org/10.1177/1747493019897870
4. Jiménez AC. Incidencia de la fibrilación auricular como factor de riesgo de infarto cerebral en pacientes del Hospital Nacional Sergio Bernales de Collique Lima. Lima: Universidad Privada San Juan Bautista; 2021. https://repositorio.upsjb.edu.pe
5. Guevara GG. Factores de riesgo en complicaciones tromboembólicas cerebrales de pacientes con fibrilación auricular permanente no valvular. Rev Mex Neuroci. 2019;20(4). https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=86229
6. Araus A, Arteaga C, Zapata-Gómez C, Ramos-Ventura C, Méndez B, Otiniano-Cifuentes R, et al. Infarto cerebral embólico de origen no determinado: más allá de la fibrilación auricular. Neurología. 2022;37(5):362-70. https://doi.org/10.1016/j.nrl.2020.07.014
7. García ERP. Características e incidencias de la fibrilación auricular en pacientes con ictus cardioembólico. Mediciego. 2020;26(2). https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=98880
8. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1-e156. https://doi.org/10.1161/CIR.0000000000001193
9. Ruff CT, Giugliano RP. Non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation: Review of the evidence and future perspectives. J Am Coll Cardiol. 2022;80(7):683-97. https://doi.org/10.1016/j.jacc.2022.05.039
10. Mou L, Norby FL, Chen LY, O'Neal WT, Lewis TT, Soliman EZ, et al. Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2023;16(1):e011232. https://doi.org/10.1161/CIRCEP.122.011232
11. Benz AP, Hohnloser SH. Stroke prevention in atrial fibrillation: A contemporary review. Eur Heart J. 2023;44(27):2425-37. https://doi.org/10.1093/eurheartj/ehad279
12. Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, et al. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N Engl J Med. 2024;390(2):107-17. https://doi.org/10.1056/NEJMoa2310234
13. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. https://doi.org/10.1161/STR.0000000000000375
14. López-Yong AR, López-Ralón O, Balcázar-Rincón LE, Galdámez-De la Cruz JJ, Chavarría-Olarte ME. Prevalencia de fibrilación auricular en pacientes con Evento Vascular Cerebral isquémico atendidos en el servicio de Urgencias. An Med Univ. 2024;7(1):12-8. https://doi.org/10.31644/AMU.V03.N02.2024.A07
15. Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke (ARCADIA) trial: Rationale and methods. Am Heart J. 2023;256:1-11. https://doi.org/10.1016/j.ahj.2022.10.082
16. Romero-Acaro F. Factores de riesgo asociados a enfermedad cerebrovascular en pacientes con fibrilación auricular, hospitalizados en el servicio de cardiología y medicina interna del Hospital Metropolitano entre enero 2013 y diciembre 2017. Quito: Pontificia Universidad Católica del Ecuador; 2020. https://repositorio.puce.edu.ec/handle/22000/17496
17. Giner-Soriano M, Casajuana M, Roso-Llorach A, Vedia C, Morros R. Efectividad, seguridad y costes de la prevención tromboembólica en fibrilación auricular. Estudio de cohortes apareado por Propensity Score. Aten Primaria. 2020;52(3):176-84. https://doi.org/10.1016/j.aprim.2019.03.010
18. Xiong X, Fan M, Ma J, Deng J. Association of atrial fibrillation and cardio-embolic stroke with post-stroke delirium susceptibility: a systematic review and meta-analysis of observational studies. World Neurosurg. 2022;166:e697-e706. https://doi.org/10.1016/j.wneu.2022.08.025
19. Saver JL, Chapot R, Agid R, Hassan AE, Jadhav AP, Liebeskind DS, et al. Thrombectomy for Distal, Medium Vessel Occlusions: A Consensus Statement on Current Knowledge and Directions for Future Research. Stroke. 2024;55(4):1106-15. https://doi.org/10.1161/STROKEAHA.123.044721
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Maytee Olivera Vega, Deborah Cabrera Rodríguez, Sara Patricia Aguilar Ocampo, Lisbel Garzón Cutiño (Author)